Back to results
UnknownPhase 1

Safety Study of Human MUC-1 (Mucin-1) Adenoviral Vector Vaccine for Immunotherapy of Epithelial Cancers

NCT02140996

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

National Cancer Centre Singapore

Singapore, Singapore

+1 additional location

Contact

Han Chong Toh, MD

+65 64368174hanchongtoh@gmail.com
View on ClinicalTrials.gov